Opko Health, Inc.

OPK Nasdaq SEC CIK 944809
Follow Opko Health Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $65.4M +15.9% vs same quarter last year
Net income −$53.5M −347.5% vs same quarter last year
EPS, diluted −$0.07 −333.3% vs same quarter last year
Operating cash flow −$36.3M −4.8% vs same quarter last year
Revenue by quarter
$183.6M
$150M
$156.8M
$56.4M
$148.5M
$124.2M
$163.6M
$65.4M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$400B−$300B−$200B−$100B$0$100BFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$606.9M−$225.7B
FY24$713.1M−$53.2B
FY23$863.5M−$188.9B
FY22$1B−$328.4B
FY21$1.8B−$30.1B
FY20$1.4B$30.6M
FY19$901.9M−$314.9M
FY18$990.3M−$153M
FY17$966M−$305.3M
FY16$1.1B−$48.4M
FY15$305.3M−$52.1M
FY14$91.1M−$171.7M
FY13$96.5M−$114.4M
FY12$47M−$29M
FY11$28M−$1.3M
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−40000%−30000%−20000%−10000%0%10000%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2533.9%−19.3%−37187%
FY2430.6%−21.3%−7463.3%
FY2336.8%−18.2%−21871.9%
FY2228.7%−22.5%−32703.3%
FY21-1.1%−1698.5%
FY20-4%2.1%
FY19-−30.4%−34.9%
FY18-−17.3%−15.5%
FY1793.7%−28.6%−31.6%
FY1649.5%−8.6%−4.3%
FY1536.7%−39.5%−17.1%
FY1489.7%−160%−188.4%
FY1389.2%−82.5%−118.5%
FY1240.7%−79.2%−61.7%
FY1138.4%−82.9%−4.6%
Free cash flowOperating cash flow minus capital expenditure
−$300M−$200M−$100M$0$100M$200MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25−$190.8M
FY24−$208.5M
FY23−$44.5M
FY22−$119.8M
FY21$6.2M
FY20$5.8M
FY19−$185.3M
FY18−$137M
FY17−$138.6M
FY16$13.5M
FY15$153.2M
FY14−$95.1M
FY13−$59.6M
FY12−$26.9M
FY11−$20.5M
Returned to shareholdersDividends paid and shares bought back
$0$25M$50M$75M$100MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearBuybacks
FY25$47M
FY24$90.2M
FY23$0
FY22$0
FY21-
FY20-
FY19-
FY18-
FY17-
FY16-
FY15-
FY14-
FY13$0
FY12$0
FY11$7.8M
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Opko Health
  • Healthcare median
−40000%−30000%−20000%−10000%0%10000%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearOpko HealthHealthcare median
FY25−37187%−30.6%
FY24−7463.3%−47%
FY23−21871.9%−58%
FY22−32703.3%−80.4%
FY21−1698.5%−71.8%
FY202.1%−62.2%
FY19−34.9%−46.2%
FY18−15.5%−49.6%
FY17−31.6%−45.9%
FY16−4.3%−36%
FY15−17.1%−37.8%
FY14−188.4%−35.5%
FY13−118.5%−37.1%
FY12−61.7%−29.1%
FY11−4.6%−27.9%